GSK extension
-
News
Parma. Gsk, Filctem: risk of strong employment contraction
Sale agreement by GSK (GlaxoSmithKline) of the anesthetics portfolio in Aspen, with the relocation of production. Strong concern, above all…
Leggi » -
News
Meningitis, GSK launches 'Take 5 for Meningitis' awareness campaign
Meningococcal meningitis is a life-threatening disease caused by the bacterium Neisseria meningitidis, and consists of severe inflammation…
Leggi » -
News
GSK, revolution at the top: after the CEO, the Vaccines Chairman also leaves
Andrew Witty, CEO of GlaxoSmithKline, isn't the only member of the company's leadership team preparing to pack his bags.…
Leggi » -
First floor
Drugs: Gsk, stop patent for access to poor countries
The British pharmaceutical giant GlaxoSmithKline (GSK) will apply differentiated patents according to wealth to guarantee access to medicines to…
Leggi » -
News
GSK confirms, CEO will leave role from March 2017
The rumors circulated in recent weeks regarding Andrew Witty's departure from GlaxoSmithKline have been confirmed. The 'long-serving' Chief Executive Officer of the group…
Leggi » -
News
Gsk vaccines will remain in Siena. The satisfaction of the unions: "We have been listened to"
The announcement is from those who make people happy, first of all the workers. Gsk, the multinational that bought Novartis, has…
Leggi » -
First floor
GSK Spain. Stop sponsoring doctors' trips to congresses. It had previously abolished sales incentives for SFIs
La controllata spagnola della casa farmaceutica britannica GlaxoSmithKline (GSK) ha deciso di non sostenere più i costi di assistenza ai…
Leggi » -
News
Making a vaccine: as difficult as sending the Shuttle into orbit
Siamo stati a Wavre, in Belgio, nel più grande centro di produzione di vaccini del mondo. Dove, oltre a 4.500…
Leggi » -
News
Great Britain. GSK fined more than 48 million for preventing the marketing of generics
L’Autorità dei mercati e della concorrenza del Regno Unito (CMA) ha comminato una multa di 37,6 milioni di sterline (48,4…
Leggi » -
News
Siena. Unions and RSU of GSK vaccines: "The development department with its 200 workers is at risk"
Il principale sito italiano per la produzione di vaccini contro la meningite perde la sua unicità. SIENA. Non per molto…
Leggi »